JSMO Japanese Society of Medical Oncology

Contact USSearchen

SearchInput the word you want to find

  • HOME
  • ABOUT JSMO
  • 2021 Award Recipients

2021 Award Recipients

2021 Award Recipients

Annals of Oncology Award
Name Affiliation Awarded Paper
Koji Haratani Department of Medical Oncology, Kindai University Faculty of Medicine

Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatmen

https://doi.org/10.1093/annonc/mdx183

Young Investigator Award
Name Affiliation Title
Yuta Adachi Division of Molecular Therapeutics, Aichi Cancer Center Research Institute EMT is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C mutant NSCLC
Takahiko Ito National Cancer Center Hospital Predictive role of tumor location in 1st-line treatment of colorectal cancer: a multicenter retrospective study of JSCCR
Yoshihiko Sakata Division of Respiratory Medicine, Saiseikai Kumamoto Hospital OSImertinib For Advanced non-small cell lung Cancer as first-line Treatment in real world setting (OSI-FACT)
Akihiro Suzuki Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine Defined Lifestyle and Germline Factors Predispose Asian Populations to Gastric Cancer
Shigeki Hirabayashi Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University Impact of pre-transplant minimal residual disease on clinical outcome of unrelated HSCT in patients with Ph+ ALL
Yuka Morita Department of Medical oncology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Impact of pegfilgrastim on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
Ahmed Abdelsalam Associate consultant of pediatric oncology at Children’s
Cancer Hospital Egypt (CCHE 57357).
Outcome of Unilateral Retinoblastoma: A 10- years Experience at Children’s Cancer Hospital in Egypt ( CCHE )
Gunn Huh Department of Internal Medicine, Liver Research Institute,
Seoul National University Hospital,
Seoul National University College of Medicine
Gemcitabine plus nab-paclitaxel for second-line therapy of pancreatic cancer: a phase II, single-arm, multicenter study
Nutthaporn Chandeying Gynecologic oncology unit,
Department of obstetric and gynecology ,
Faculty of Medicine Vajira Hospital, Navamindradhiraj University
Comparison of psychological, exercise, and music treatments for children and adolescence with cancer: A Meta-analysis
Jessa Gilda Pandy(※) Section of Medical Oncology,
St. Luke’s Medical Center
Risk Factors and Clinical Outcomes of Systemic Cancer Treatment Delay among Cancer patients during the COVID-19 Pandemic
Timotius Hariyanto(※) Faculty of Medicine, Pelita Harapan University The Impact of Chemotherapy for Cancer Patients With COVID-19 on Severity and Mortality Outcomes: A Meta-Analysisc

※Titles omitted, listed in Japanese alphabetical order.

※Affiliations are listed as of the time of the award.

Scenes from the Award Ceremony

Scenes from the Award Ceremony

※Click to view a larger image.